Oesophageal + Stomach disorders Flashcards

1
Q

What is the epithelium of the stomach?

A

columnar epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the disease of Achalasia?
(4)

A
  1. Degenerative loss of ganglia from the Auerbach’s plexus.
  2. Impaired peristalsis of the oesophagus
  3. lower oesophageal sphincter is unable to relax
  4. Overall leads to dilation of the oesophagus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical features of Achalasia?
(3)

A
  1. Progressive dysphagia of BOTH foods and liquids
  2. Regurgitation of undigested food
  3. Chest pain, heartburn and weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the investigations for Achalasia? (2)

A

Gold standard;
1. Oesophageal manometry
* Excessive LOS tone which does not relax on swallowing.

  1. Barium swallow : expanded oesophagus - ‘Bird’s beak’ appearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the first line management of Achalasia

A

Pneumatic balloon dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the gold standard management of Achalasia?

A

If persistent symptoms
* Heller Cardiomyotomy
: a laproscopic procedure where a small cut in made in the lower sphincter to relive the pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the options for management for Achalasia?

A
  1. First line : Pneumatic balloon dilation
  2. Second line :
    Heller Cardiomyotomy : a laproscopic procedure where a small cut in made in the lower sphincter to relive the pressure
  3. Third line :
    Intra-sphincteric injection of botulinum toxin to relax sphincter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pathophysiology of Barret’s oesophagus?
(3)

A
  1. Metaplasia of the lower oesophageal mucosa where normal squamous epithelium is replaced by columnar epithelium
  2. Occurs through chronic acid exposure, causes chronic irritation and metaplasia.
  3. This results in an increased risk of oesophageal adenocarcinoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the risk factors associated with Barret’s oesophagus? (4)

A

GORD, Male gender, smoking, haitus hernia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is Barret’s oesphagus diagnosed? (3)

A
  1. OGD and bisosy
  2. goblet cells present which indicates indicates metaplasia,
  3. May progress from metaplasia to dysplasia eventually resulting adenocarcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the management options of Barrett’s oesophagus (6)

A
  1. High dose proton pump inhibitor - reduces change of progression to dysplasia or limits region of metaplasia
  2. Endoscopic surveillance with biopsy
  3. i ) patients with identified metaplasia need monitoring endoscopies every 3-5 years
  4. ii ) If dysplasia is identified - Endoplasmic intervention is offered
    • Radiofrequency ablation for low grade dysplasia
    • Endoscopic muscosal resection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the definition of GORD?

A

characterised by the reflux of stomach acid and bile into the oesophagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the clinical features of GORD? (5)

A
  1. heartburn
  2. regurgitation
  3. chest pain, belching,
  4. Acid Brash
  5. odynophagia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the complications of GORD?

A
  1. Oesophagitis
  2. Barrett’s oesophagus
  3. Oesophageal adenocarcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the risk factors which cause GORD? (5)

A
  1. Obesity
  2. Smoking, alcohol excess
  3. Haitus hernia
  4. Drugs which relax the LOS -
  5. Tricyclic antidepressants, nitrates, CCB, NSAIDs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What drugs increase the risk of GORD and how? (4)

A

Drugs which relax the LOS -
* Tricyclic antidepressants
* nitrates
* CCB
* NSAIDs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which drugs cause dyspepsia? (3)

A
  1. NSAIDS
  2. Bisphosphonates
  3. Steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the definition of ‘Mallory-Weiss syndrome’

A
  1. Severe vomiting causes sudden increase in intra-abdominal pressure
  2. leading to partial thickness laceration, involving mucosa and submucosa but not the muscular layer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the risk factors for Mallory Weiss syndrome? (4)

A
  1. Alcoholism
  2. bulimia
  3. hiatal hernia
  4. hyperemesis gravidarum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the clinical features of Mallory-Weiss syndrome (4)

A
  1. Haematemesis following severe vomiting or retching
  2. Marlena
  3. Epigastric/back pain
  4. Signs of haemodynamic instability - hypotension, tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What investigations are indicated in Mallory Weiss syndrome?

A
  1. . Endoscopy
  2. FBC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the management of Mallory Weiss syndrome?

A
  1. Supportive management with IV fluids
  2. IV PPI
  3. Endoscopic band ligation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the definition of Boerhaave syndrome?

A
  1. Spontaneous rupture esophagus - full thickness tear
    typically as a result of
  2. Sudden increase in intraesophageal pressure combined with poor esophageal wall integrity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the cause of Boerhaave syndrome?

A
  1. Associated with severe vomiting or retching,
  2. Leading to a sudden increase in intrathoracic and intraabdominal pressures.
  3. The increased pressure can cause a rupture in the weakened esophageal wall.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the risk factors of Boerhaave syndrome?

A

Oesophagitis, Barrett’s oesophagus, ulcers, stricture dilatation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the clinical features associated with Boerhaave syndrome?

A
  1. Mackler’s triad : Chest pain, vomiting, subcutaneous emphysema - ‘crunching sound’ over heart beat caused by mediastinal emphysema
  2. Severe vomiting
  3. Severe chest or abdominal pain localised to epigastric region or back pain,
  4. Tachypnea, dyspnea, cyanosis, fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which investigations are indicated in Boerhaave syndrome?

A
  1. Diagnosis: Avoid endoscopy as this may worsen tear
  2. CXR : pleural effusion
  3. CT scan : oesophageal wall oedema, mediastinal widening, pneumothorax
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Boerhaave syndrome : complications? (3)

A
  1. Chemical mediastinitis: gastric contents enter and contaminate the mediastinum
  2. Pleural effusion : can rupture the pleural cavity resulting in pleural effusion
  3. Sepsis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the management of Boerhaave syndrome?

A
  1. V PPI
  2. Prophylactic antibiotics
  3. Surgical management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the definition of Oesenophillic oesophagitis?

A

Allergic reaction to ingested food - results in oesophageal inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the clinical features of Oesenophillic oesophagitis? (4)

A
  1. Pain and dysphagia
  2. Strictures and fibrosis of oesophagus
  3. Regurgitation or food impaction
  4. Weightloss - result of being off food
32
Q

Oesenophillic oesophagitis : investigations for diagnosis? (2)

A
  1. PPI trail : no improvement with PPI - r/o GORD
  2. Endoscopy with oesophageal biopsy - dense eosinophil infiltrate and stricture
33
Q

Oesenophillic oesophagitis : Management (3)

A
  1. Dietary modification - exclude foods assoc with allergies such as egg, nuts, soy etc
  2. Topical solution of steroids - fluticasone
  3. Surgery - oesophageal dilatation to reduce sx of strictures
34
Q

Oesenophillic oesophagitis : Complications (3)

A

Strictures, Mallory-weiss tear, Impaction of food which may need endoscopic intervention to remove.

35
Q

What are the two main types of oesophageal cancer and their incidence rates?

A
  1. Squamous cell carcinoma: most common in the developing world
  2. Adenocarcinoma: most common in the developed world - US/UK
36
Q

Oesophageal cancer : location and causes of Squamous cell carcinoma?

A
  1. Upper 2/3 of the oesophagus
    Causes :
  2. Smoking
  3. Alcohol,
  4. Achalasia
37
Q

Oesophageal cancer : location and adenocarcinoma cell carcinoma? (3)

A
  1. Originates in the columnar glandular epithelium - lower 1/3 of the oesophagus
    * Causes :
  2. GORD or Barrett’s oesophagus, repeated oesophagitis from the acid reflux
    * replaces the squamous epithelium with columnar epithelium similar to the intestines this process is called metaplasia, which is better at withstanding acidic environment
38
Q

Oesophageal cancer : clinical features? (3)

A
  1. Dysphagia (most common presenting symptom)
  2. Anorexia, weight loss,
  3. Vomitting
39
Q

Oesophageal cancer : Investigations for diagnosis? (3)

A
  1. Upper GI endoscopy with biopsy
  2. Endoscopic ultrasound for regional staging
  3. CT scan can be used for initial staging : Stages according to the TNM system, T for tutor size, N for lymph node metastases, M for distal metastases.
40
Q

Oesophageal cancer : Management (2)

A
  1. Surgical resection
  2. Oesophagectomy with adjuvant chemotherapy
41
Q

H.pylori : Associated diseases? (4)

A
  1. Gastritis
  2. Peptic ulcer disease
  3. Gastric cancer,
  4. B-cell lymphoma of MALT fissure,
42
Q

H.pylori : Pathophysiology of disease (2)

A

H-Pylori has 2 main mechanisms to survive in the acidic gastric environment
1. Secrete urease which converts urea into ammonia -> alkalisation of the acidic environment -> H. Pylori are better able to survive
2. Release bacterial cytotoxin such as cytotoxin A which causes epithelial cell death and exposes the underlying mucosal layers to gastric acid -> this in turn can lead to ulcer formation.

43
Q

H.pylori : Investigations for diagnosis? (4)

A

1. FIRST LINE :
Urea breath test - not to be performed within 4 weeks of treatment with antibiotic or PPI - can also be used to check for H. Pylori eradication

  1. Rapid urease test - biosy sample is mixed with urea and PH indicator, colour change if H pylori urease activity
  2. Stool antigen test
  3. Gastric biospy
44
Q

H.pylori : Guidance before investigation for diagnosis?

A

Urea breath test should not be performed
* <4 weeks after antibiotic therapy
* <2 weeks after PPI use

45
Q

H.pylori : Management? (2)

A

PPI + Amoxicillin + Clarithromycin/Metronodizole (7 day course)
If allergic to penicillin; PPI + Clarithromycin +Metronidazole

46
Q

Which is the test recommended to confirm H.pylori eradication?

A

Urea breath test - only test recommended

47
Q

Peptic Ulcer : What are the two types? (2)

A

Gastric ulcers - form in the lesser curvature of the antrum
Duodenal ulcers - develop right after the pyloric sphincter

48
Q

Peptic ulcer : Causes (3)

A
  1. H. Pylori : secretes proteases which damages mucosa
  2. NSAIDs : inhibit cyclooxyrgenase which synthesises prostaglandins, lower levels of prostaglandins leaves the mucosa susceptible to damage
  3. Zollinger Ellinson syndrome (Gastrinoma) : neuroendocrine Timor which secretes an abnormal levels of gastrin, this stimulate parietal cells to release excess HCL.
49
Q

Gastric ulcer : Clinical features

A
  1. Increased pain on eating, thus assoc with weightloss
50
Q

Gastric ulcer : Complications

A
  1. Erode into the left gastric artery leading to a haemorrhage
51
Q

Duodenal ulcer : Clinical features

A
  1. Pain decreases on eating, thus assoc with weight gain
52
Q

Duodenal ulcer : Complications (3)

A
  1. Erodes on the posterior wall of the duodenum eroding into the gastroduadenal artery
  2. Referred pain in the shoulder : Perforation, air can collect under the diaphragm, irritating the phrenic nerve.
  3. If close to pyloric sphincter - can lead to oedema and gastric outlet obstruction
53
Q

Peptic ulcer : investigations for diagnosis?

A
  1. Upper endoscopy
54
Q

Peptic ulcer : Management (4)

A
  1. Dietary and lifestyle adjustments
  2. PPI and H2 receptor antagonist : reduce stomach acid production
  3. Eradication of H.Pylori + Antibiotic therapy
  4. Endoscopic therapy : if high risk of bleeding, consider endoscopic haemostatic clips
55
Q

Gastric cancer : Adenocarcinoma - histology/cause?

A

Adenocarcinoma - most common type of GI cancer
Histology : Arises from the columnar epithelium
Cause : is H. Pylori bacteria which causes chronic gastritis resulting in metaplasia

56
Q

Gastric cancer : Risk factors

A

Blood group A: Individuals with blood group A have been found to have a higher risk of developing gastric cancer

Pernicious anaemia: Pernicious anaemia is an autoimmune condition that results in vitamin B12 deficiency due to impaired absorption in the stomach.
This condition causes chronic inflammation and atrophy of the gastric mucosa, which can eventually lead to gastric cancer.

H. pyloriinfection: It is well established that chronic infection withH. pylori, a gram-negative bacterium that colonises the stomach lining, significantly increases the risk of gastric cancer

Smoking: Smoking is a significant risk factor for many types of cancers including gastric cancer

57
Q

Gastric cancer : MALT Lymphoma

A

Origin : Gastric cancer arising from Lymphoid tissue associated with mucous membrane - part of the immune system found in the gastrointestinal tract.
Cause :
Chronic H.pylori infection - triggers excessive B cell proliferation which increases likelihood of mutation into a lymphoma

58
Q

Gastric cancer : Carcinoid Tumor

A

Origin cancer : Gastric cancer arising from neuroendocrine G-cells in the stomach.

59
Q

Gastric cancer : Investigations for diagnosis?

A
  1. Gastro-duoadenoscopy with biopsy - signet ring cells present
  2. CT scan - staging
60
Q

Gastric cancer : Management

A

Partial or complete gastrectomy with chemotherapy

61
Q

2WW criteria for Oesophageal and Stomach cancer : criteria

A

Urgent Endoscopy within 2 weeks for the following;

  • All patients with dysphafia
  • All patients with upper abdominal mass consistent with stomach cancer
  • Patients >55 with weightloss and
  • Upper abdominal pain
  • Reflux
  • Dyspepsia
62
Q

Mx of dyspepsia - without red flag sx

A

This can be summarised at a step-wise approach
* 1.Review medicationsfor possible causes of dyspepsia
* 2. Lifestyle advice
* 3. Trial of full-dose proton pump inhibitor for one month OR a ‘test and treat’ approach forH. pylori
* if symptoms persist after either of the above approaches then the alternative approach should be tried

63
Q

Non urgent endoscopy criteria?

A
  1. Haematemesis
  2. Treatment resistent dyspepsia
  3. Upper abdomina pain with
    - Low Hb
    - Raised platelets
  4. N+V with weightloss,dyspepsia, upper abdopain
64
Q

PPI : Mechanism of action?

A

MOA : irreversible blockage of H+/K+ ATPase of gastric parietal cells

65
Q

PPI : Side effects?

A
  1. Hyponatremia (Low Na+)
  2. Hypomagnesaemia (Low Mg2+)
  3. Osteoporosis - increases risk of fractures
  4. Microscopic colitis - can present as chronic diarrhea
  5. Increased risk of C.diff infections
66
Q

Clostridium Difficile : Pathophysiology of disease?

A
  • Anaerobic Gram+ rod common in hospital setting
    1. Anaerobic G+ rod which produces an exotoxin which target intestinal epithelial cell and cause inflammation of the intestinal tissue
    2. Results in a syndrome called pseudomembranous colitis.

* Transmission- via faecal oral route

67
Q

Clostridium Difficile : Risk factors?

A
  1. Broadspectrum antibiotics : suppression of normal gut flora by broad spectrum antibiotics ( Clindamycin and 2/3rd gen cephalosplorins such as cefexime
  2. PPI (Omeprazole)
68
Q

Clostridium Difficile : Clinical features?

A
  1. Diarrhea
  2. Abdominal pain
  3. Raised WCC count - the higher the WCC + any assoc systemic features the more severe the disease
69
Q

Clostridium Difficile : Investigations for diagnosis?

A

Stool sample : C.diff toxin

70
Q

Clostridium Difficile : Management of first episode

A
  1. Review and stop current antibiotic therapy
    * First episode of C.diff infection
  2. First line : Oral vancomycin for 10 days
  3. Second line.: Oral fidaxomicin
  4. Third line therapy : Oral vancomycin +/- IV metronidazole
71
Q

Clostridium Difficile : Management of second episode

A

Recurrent episode - recurrent infection in 20% of patients
1. Within 12 weeks since last infection - oral fidaxomicin
2. After 12 weeks since last infection - oral vancomycin or fidaxomicin

72
Q

Acute upper GI bleed : Clinical features

A
  1. Haematemesis - bright red or occasional coffee ground
  2. Meleaena - black, tarry stool
  3. Raised urea
73
Q

Acute upper GI bleed : Causes

A
  1. Oesophageal varices
  2. Oesophagitis
  3. Mallory weiss tear
  4. Peptic ulcer perforation
74
Q

Acute upper GI bleed : Prevention measures

A
  1. Propanolol - reduced rebleeding and mortality
  2. Endoscopic bind ligation - primary prevention of patient with liver cirrhosis and medium-large oesophageal varices
75
Q

Acute upper GI bleed : Management

A
  1. GBS score - raised urea, low Hb, reduced BP
  2. Rockall score - used after endoscopy, to assess risk of rebleeding and mortality
  3. Blood transfusion
  4. Endoscopy within 24 hours
76
Q

Variceal bleed : Management

A
  1. Telipressin and prophylactic antibiotics
  2. Band litigation